This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE — Description, Dosage, Side Effects | PillsCard
OTC
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
EQ 3.75MG BASE;23MG, Capsule, extended release
INN: PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Data updated: 2026-04-25
Available in:
🇬🇧
Form
CAPSULE, EXTENDED RELEASE
Dosage
EQ 3.75MG BASE;23MG
Route
ORAL
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
VIVUS LLC
ATC Code
A08AA01
Source
FDA_OB · 022580
A08AA51(WHO)QA08AA51(WHO)
US:Schedule IVIn general: ℞ (Prescription only)
960078-81-3
56842108
D11710
DTXSID20242081
Phentermine/topiramate, sold under the brand nameQsymia, is acombination drugofphentermineandtopiramateused to treatobesity.It is used together with dietary changes and exercise.If less than 3% weight loss is seen after 3 months it is recommended the medication be stopped.The weight loss is modest.Effects on heart related health problems or death is unclear.
Common side effects include tingling, dizziness, trouble sleeping, and constipation.Serious side effects may includesuicide,abuse.Use is not recommended duringpregnancy.Phentermineis astimulantandappetite suppressant.Topiramateis ananticonvulsantthat has weight loss side effects.The exact mechanism of action for both drugs is unknown.
Phentermine/topiramate was approved for medical use in the United States in 2012.In October 2012, approval was denied in Europe, due to concerns regarding safety.